08/02/2019
In this podcast, Stewart Tepper, MD, talks about the science of cluster headache, the changes in the clinical management of cluster headache, and how recent treatment options have improved the management of cluster headache.
Additional Resources:
- Balbi A. FDA approves first treatment for episodic cluster headaches [published online June 5, 2019]. Neurology Consultant. https://www.consultant360.com/exclusive/neurology/migraine/fda-approves-first-treatment-episodic-cluster-headaches. Accessed July 5, 2019.
- Potts M. FDA approves new preventive migraine treatment [published online September 17, 2018]. Consultant360. https://www.consultant360.com/exclusive/neurology/migraine/fda-approves-new-preventive-migraine-treatment. Accessed July 5, 2019.
- Silberstein SD, Dodick DW, Bigal ME, et al. Fremanezumab for the preventive treatment of chronic migraine. N Engl J Med. 2017;377:2113-2122. doi:10.1056/NEJMoa1709038.
- Vogt C. Galcanezumab deemed safe, effective for migraine [published online May 31, 2018]. Neurology Consultant. https://www.consultant360.com/exclusives/new-drug-deemed-safe-effective-episodic-migraine. Accessed July 5, 2019.
Stewart J. Tepper, MD, is a professor of neurology at the Geisel School of Medicine at Dartmouth College and the director of the Dartmouth Headache Center at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.
